Add BrightSurf on Google Email

Targeting histone modifications in colorectal cancer: therapeutic potential of epigenetic modifiers on acetylation, methylation and phosphorylation

Epigenetic modifiers targeting histone acetylation, methylation, and phosphorylation show significant preclinical promise in CRC. Combination strategies and novel degraders offer pathways to overcome resistance, including PROTACs targeting KDM3A/B that eliminate cancer stem cells via Wnt/β-catenin inhibition.

SourceXia & He Publishing Inc.·JournalGene Expression·DateMar 26, 2026

Forging a novel therapeutic path for patients with Rett Syndrome using AI

Researchers at the Wyss Institute have identified vorinostat as a promising treatment for Rett Syndrome using an AI-driven drug discovery process and innovative disease modeling. The findings demonstrate disease-modifying abilities across multiple tissues, offering hope for a potentially curative treatment.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalCommunications Medicine·TypeComputational simulation/modeling·DateJul 2, 2025

How the genome is packed into chromosomes that can be faithfully moved during cell division

The Gerlich Group at IMBA found that histone acetylation establishes a sharp surface boundary on chromosomes, resisting microtubule perforation. Chromatin phase separation and DNA looping by condensin cooperates to build mitotic chromosomes with unique physical properties.

A ‘factory reset’ for the brain cures anxiety, drinking behavior

Researchers at the University of Illinois Chicago found that gene editing can reverse epigenetic changes in the brain caused by adolescent binge drinking, leading to a decrease in anxiety and excessive drinking behavior. The study used CRISPR-dCas9 technology to manipulate histone acetylation and methylation processes at the Arc gene.

SourceUniversity of Illinois Chicago·JournalScience Advances·TypeExperimental study·DateMay 4, 2022